---
title: Hep3B Orthotopic Model - TD2 Precision Oncology
description: Hep3B is a hepatocellular carcinoma cell line widely used for liver cancer research. Explore HCC biology and therapeutic interventions using Hep3B.
image: https://td2inc.com/hubfs/Assets/GraphsFigures/hep3b.png
---
×
[](https://td2inc.com/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
# Hep3B Orthotopic Model
**Synonyms:** -
Hep3B is a well-established human hepatocellular carcinoma (HCC) cell line widely used in liver cancer research. It exhibits characteristics of HCC, including growth in anchorage-independent conditions and the expression of liver-specific markers. Hep3B is a valuable tool for investigating HCC biology, evaluating therapeutic interventions, and screening anti-cancer agents. Researchers utilize this cell line to study liver cancer pathogenesis, identify potential targets, and develop novel treatment strategies.
## Model Details
**Cancer Type:** Liver Canacer
**Model Name:** Hep3B
**Mouse Strain:** Nu/Nu
**Treatment Data Available:** N/A
## Hep3B Survival
Survival of Hep3B after orthotopic intrahepatic injection of Nu/Nu mice (n=5)
### Request Additional Syngeneic Model Data
## CONTACT US
## Get Started.
Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.
[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
Office
13208 E. Shea Blvd,
Suite 100
Scottsdale, AZ 85259
Phone
(602) 358-8300
Connect with us
-
-
© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)